Patents by Inventor Generoso Bevilacqua

Generoso Bevilacqua has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of diagnosing cancer susceptibility or metastatic potential
    Patent number: 5753437
    Abstract: The present invention relates, in general, to a method for diagnosing cancer susceptibility based on alterations in the nm23 gene. In particular, the present invention relates to a method of identifying individuals at risk for developing a primary cancer or at risk for suffering treatment failure, morbidity, or mortality associated with cancer. The invention further relates to a means of using genetic methods to predict individuals at increased risk for developing distant metastases.
    Type: Grant
    Filed: February 28, 1995
    Date of Patent: May 19, 1998
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: Patricia S. Steeg, Lance A. Liotta, Alvaro Leone, Generoso Bevilacqua
  • Kit for diagnosing cancer metastatic potential
    Patent number: 5049662
    Abstract: A new NM23 gene and its relationship with metastatic potential of tumor cells is described.
    Type: Grant
    Filed: October 13, 1987
    Date of Patent: September 17, 1991
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Patricia S. Steeg, Lance A. Liotta, Mark E. Sobel, Generoso Bevilacqua